Forbion announces that Pfizer acquires interest in its portfolio Company AM-Pharma
Posted on May 12, 2015 in Forbion, Forbion highlight, Highlights
Pfizer acquires minority interest in AM-Pharma; Secures option to acquire company.
Option may be exercised based on Phase II trial results for recombinant human Alkaline Phosphatase.
PRESS RELEASE Forbion announcement Pfizer interest AM-Pharma
